AstraZeneca Pharma
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Pharmaceuticals
 |
Cash Flow of AstraZeneca Pharma |
------------------- in Rs. Cr. ------------------- |
| Dec '04 | Dec '05 | Dec '06 | Dec '07 | Dec '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Net Profit Before Tax | 43.69 | 64.78 | 74.95 | 95.35 | 114.38 | |||||
| Net Cash From Operating Activities | 49.30 | 28.09 | 54.62 | 39.71 | 81.65 | |||||
| Net Cash (used in)/from Investing Activities |
-5.94 | -4.16 | -2.46 | -2.70 | 5.26 | |||||
| Net Cash (used in)/from Financing Activities | -2.20 | -28.00 | -11.30 | -33.97 | -54.14 | |||||
| Net (decrease)/increase In Cash and Cash Equivalents | 41.15 | -4.08 | 40.85 | 3.03 | 32.77 | |||||
| Opening Cash & Cash Equivalents | 30.07 | 71.22 | 67.15 | 108.00 | 111.04 | |||||
| Closing Cash & Cash Equivalents | 71.22 | 67.15 | 108.00 | 111.04 | 143.80 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore AstraZeneca connections | ||||||||||
| ||||||||||
